GWB... You 'll be pleased to know that Immunocidin is now being advertised in Clinician's Brief, which is what could be called the main journal of the NA vet community.
Of interest, the term "cancer" is featured very prominently in the ads I was emailed. Also of interest, is that they are very openly marketing the 88% cure rate of Immunocidin and the fact that studies have indicated its effectiveness on several other forms of canine cancer... Reminded me of that idea of liberal "off label" use amongst vets.
The ads themselves direct you to Immunicidin.com. I am assuming that once there you would locate one of the 6 or 7 distributors in the US.
I am sure that it is simply a last ditch attempt at generating sales before the inevitable, but it is odd that just a few short months ago, Bioniche seemed very reluctant to use the term "cancer" in any of the news releases involving Immunocidin. You know the ones shareholders and the market in general would have seen?
" Cancer treatment " and "88% cure rate" does have a certain negative connotation to it, doesn't it??? It jumped off the page when I saw it. And here I thought that Immunocidin was used in something called canine mammory carcinoma. That is how it was described its is NR on Thanksgiving eve launching it.
Certainly however, you could see why they wouldn't have interest in any unwanted attention from shareholders or potential investors. Who needs to hear about cancer, haven't we been demoralized enough?... Apparently, all is good now though, and the terminology seems to flow quite freely in these rather obscure veterinary industry magazines.
Then again, if you weren't a vet, a board stiff patron in one of their waiting rooms, or abstockhouse reader at midnight, you wouldn't be aware of it would you?